stoxline Quote Chart Rank Option Currency Glossary
  
(HHT)
  0 (0%)    03-28 09:15
Open:
High:
Volume: 0
  
Pre. Close:
Low:
Market Cap: 0(M)
Technical analysis
2024-03-28 8:45:36 AM
Short term     
Mid term     
Targets 6-month :  37.6 1-year :  43.92
Resists First :  32.2 Second :  37.6
Pivot price 30.68
Supports First :  30.56 Second :  29.54
MAs MA(5) :  30.55 MA(20) :  30.74
MA(100) :  31.68 MA(250) :  30.67
MACD MACD :  -0.3 Signal :  -0.3
%K %D K(14,3) :  35.2 D(3) :  32.9
RSI RSI(14): 52.4
52-week High :  35.65 Low :  26.78
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ HTH ] has closed below upper band by 36.1%. Bollinger Bands are 17.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 31.09 - 31.28 31.28 - 31.46
Low: 29.94 - 30.16 30.16 - 30.37
Close: 30.73 - 31.06 31.06 - 31.37
Company Description

Headline News

Thu, 29 Feb 2024
He was diagnosed with a rare genetic disease in high school. As a Pitt postdoc, he's committed to finding answers. - University of Pittsburgh

Wed, 28 Feb 2024
To Test or Not to Test: A Case Report on Hereditary Hemorrhagic Telangiectasia - Cureus

Wed, 13 Dec 2023
Pomalidomide Cuts Severe Epistaxis in Genetic Bleeding Disorder - Medpage Today

Tue, 17 Oct 2023
uAUG creating variants in the 5'UTR of ENG causing Hereditary Hemorrhagic Telangiectasia | npj Genomic Medicine - Nature.com

Sat, 09 Sep 2023
Homoharringtonine as a PHGDH inhibitor: Unraveling metabolic dependencies and developing a potent therapeutic ... - ScienceDirect.com

Mon, 21 Aug 2023
UHealth Certified as HHT Center of Excellence - Florida Hospital News and Healthcare Report - South Florida Hospital News

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
Sector:
Industry:
Shares Out 65 (M)
Shares Float 46 (M)
Held by Insiders 29.3 (%)
Held by Institutions 58.3 (%)
Shares Short 766 (K)
Shares Short P.Month 915 (K)
Stock Financials
EPS 1.69
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 32.58
Profit Margin 9.3 %
Operating Margin 13.6 %
Return on Assets (ttm) 0.7 %
Return on Equity (ttm) 5.5 %
Qtrly Rev. Growth -0.3 %
Gross Profit (p.s.) 0
Sales Per Share 18.11
EBITDA (p.s.) 0
Qtrly Earnings Growth 13.1 %
Operating Cash Flow 443 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio 18.38
PEG Ratio 1.3
Price to Book value 0.95
Price to Sales 1.71
Price to Cash Flow 4.56
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android